Imfinzi 500 MG/10 ML vial 10ML
Ended Awarded
- Contract number
- SPE2DB25FY8CW
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $15,166
Award facts
- Contract value 100% obligated
- $15,166.29 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $15,166.29 firm fixed-price delivery order to AmerisourceBergen Drug Corp on July 21, 2025, for IMFINZI 500 mg/10 mL vials. This is a non-set-aside competitive award with an ultimate completion date of August 11, 2025, and represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical. The product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. IMFINZI (durvalumab) is a checkpoint inhibitor immunotherapy used in oncology applications, reflecting the breadth of pharmaceutical products that AmerisourceBergen supplies through its federal contracts.
This delivery order falls under AmerisourceBergen's comprehensive $999.99 billion Indefinite Delivery Contract with DLA Troop Support Medical (designated SPE2DX) that extends through December 2026. As a major pharmaceutical distributor, AmerisourceBergen serves as a critical vendor for military and veteran healthcare systems, supplying specialty medications, brand-name and generic drugs, vaccines, and medical supplies across multiple therapeutic domains to support defense and civilian healthcare programs globally. The company's consistent receipt of competitively awarded contracts demonstrates its capability to fulfill federal medical procurement requirements at various transaction values.
Quick answers
Who was awarded contract SPE2DB25FY8CW?
SPE2DB25FY8CW was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on July 21, 2025.
How much is contract SPE2DB25FY8CW worth?
The government has obligated $15,166 on SPE2DB25FY8CW.
Is contract SPE2DB25FY8CW an order under another contract?
Yes. SPE2DB25FY8CW is a delivery order under SPE2DB22D3301, an indefinite delivery contract.
Was contract SPE2DB25FY8CW competed?
The extent of competition for SPE2DB25FY8CW was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award